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Highlights
The increasing incidence of tuberculosis infection and active disease
in the United States raises significant issues because much of the
increase has occurred in populations involved with the criminal
justice system. Persons with TB,
moreover, afe often also infected
with HIV. In addition, new strains
of drug-resistant TB have appeared
in part because of patients' failure
to follow prescribed courses of
medication. Unless inmates with
TB infection and disease are identi:d and appropriately treated
while incarcerated, TB-including
drug-resistant TB---can later develop among released inmates,
who then may transmit the infection to their families, community
corrections officials, and the
general public.
Challenges and opportunities facing the criminal justice community
concern:
• Screening inmates, parolees,
probationers, and criminal justice
staff for TB infection and active
disease.
• Controlling the spread of the
disease through:
- Providing training and
education to staff in under
standing how the infection is
transmitted and what can be
done to contain its spread.

continued on p.2
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The resurgence of tuberculosis (TB) in
the United States, the occunence of several major outbreaks of TB in prisons,
and the concentration in prisons and
jails of persons at high risk for TB suggest the need for treatment and control
measures at all phases of the systemfrom pretrial release to incarceration to
parole. The population that comes under
the supervision of the criminal justice
system is at relatively high risk for TB.
This population tends to be poor and
includes dispropm1ionate numbers of
racial and ethnic minorities, recent immigrants from high-incidence countries,
injection drug users, and individuals infected with HIV. In general, this population is characterized by poor access to
health care.

to the community at large. Parole and
probation officers may also be at risk
of infection through contact with their
clients.

Conectional facilities may be high-risk
settings for TB transmission because of
overcrowding, inadequate ventilation,
and high concentrations of TB infection
and disease. Inmates released into the
community pose special problems. They
may carry TB infection or disease with
them; and if they interrupt their course
of treatment, their disease may become
drug resistant and thus all the more
dangerous to them, their families, and

This Research in Action presents an overview of tuberculosis as a criminal justice
and public health issue and discusses the
particular problem ofTB in community
conections. It reports on six examples
of TB control efforts in community corrections and summarizes some of the problems and benefits that can be expected.
Special attention is given to inmates
released on parole, but the policies and
strategies discussed can be tailored
to other community corrections settings.

Many prison and jail systems have active
screening programs for identifying inmates
with TB infection and disease and for providing appropriate treatment. What happens when individuals on TB therapy
return to the community? The probation
and parole agencies that supervise them
could work with public health departments
to identify clients with TB infection and
disease and encourage compliance with
prophylactic and treatment regimens.
Although such opportunities for TB control may exist, there are challenges to
translating them into action.
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Detection and transmission

Highlights
continued . ..
- Establishing protective
procedures for staff.
- Ensuring prophylactic therapy
for infected inmates and an
appropriate medical regimen
for those with active disease.
- Linking with public health
agencies to ensure followup
with releasees.
An examination of six community
corrections jurisdictions indicated
that the development and implementation of effective policies and procedures for TB control involve close
cooperation with State and local
health departments.
Challenges to establishing effective
interagency cooperation include differences in perceptions of roles and
responsibilities between justice and
public health agencies. However,
where effective TB control programs
already exist in community corrections agencies, health departments
have been key players; they have
provided training and other educational materials, screening and treatment services, as well as coordination
of treatment for inmates released
while receiving TB treatment or preventive therapy.

The resurgence of TB as a public health
problem is the result of the association of
TB with the HIV epidemic, immigration
from countries where TB is common ,
transmission ofTB in congregative settings (e.g., correctional facilities), and
the de-emphasis and dismantling of a
national detection and control infrastructure. Moreover, the increased risk of exposure resulting from rising rates of TB
infection and disease is exacerbated by
the presence of HIV infection in the
same populations.
Tuberculous infection in persons with
intact immune systems does not typically
progress to active disease within the first
year or two of infection and may never
do so. An initial infection typically goes
unnoticed. The infection generally enters
a latent phase after a few weeks, where
it may remain dormant or ~ay become
active at a later time (see "Tuberculosis
Glossary"). Early signs of active disease
include fever, chills, fatigue, weight loss,
and night sweats.
Susceptibility to TB is thought to increase among persons with damaged or
suppressed immune systems. It has been
shown that where co-infection with HIV
exists, an individual is far more likely
to develop active and infectious TB disease. In a New York State prison study,
for example, HIV -infected prisoners
were not necessarily more likely to become infected with TB, but they were
far more likely to develop active disease
once infected than were HIV -negative
prisoners. 1
Detection. Infection with TB is generally
detected through the standard tuberculin
skin test (also known as a PPD or Mantoux test). In individuals with compromised immune systems (caused 'by HIV
infection, another disease like leukemia,
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or a history of chemotherapy or treatment with steroids), a phenomenon
called anergy often leads to false negative skin test results. Anergy testing can
help to distinguish a true negative from a
false negative skin test result. However,
the Centers for Disease Control and
Prevention (CDC) recommend that "all
HIV -infected persons-whether anergic
or not-should receive a chest radiograph and further diagnostic evaluation
if indicated." 2
Transmission. TB is not usually a highly
contagious disease but, given the right
conditions (such as crowding, poor ventilation and increased close contact with
persons with active disease), the probability of transmission increases significantly. Persons with active pulmonary
TB can spread the disease through
coughing, sneezing, laughing, or other
means that result in the propulsion of
ai rborne droplets carrying the bact. ri a.
Prolong d, close exposure is as. o ·ialed (
with increased rates of transmission. It
is possible to contract TB from contaminated articles or dust, but this is very
rare. Persons with extrapulmonary TB do
not normally represent a public health
risk (see "Tuberculosis Glossary").
A constellation of factors often exists in
prisons and jails that makes the transmission of TB more likely than in other
settings. These factors include crowding,
old and inadequate ventilation systems,
and the concentration in close quarters
of people at elevated risk for TB due to
substance abuse and poor access to
health care. Individuals with HIV who
become infected with TB are far more
likely to become infectious to others because of the increased probability that
their infection will progress to active
pulmonary disease. Correctional populations and the communities from which
inmates generally come may also includ,
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,Teater numbers of immigrants from
countries with high rates of TB.
A serious outbreak of multidrug resistant TB (MDR-TB) in New York State
prisons in 1990-91, which claimed the
lives of 36 inmates and one correctional officer, helped to focus national
attention on this problem. However,
this outbreak was not the first indication that a TB problem existed in
prison. A survey conducted by the
Centers for Disease Control and Prevention (CDC) in 1984--85 found that
in the 29 States studied, the incidence
of TB disease among inmates was more
than three times the rate in the total
population of those same States. CDC
also noted the occurrence of at least
ll TB outbreaks in the prisons of 8
States between 1985 and 1989. In fact,
studies dating back at least to 1950
have shown that the incidence of TB
: s higher in prisons than in the total
,JOpulation.3
Prison inmates are often moved from
facility to facility. This mobility provides new opportunities to spread
infection. Almost all inmates return
to the communities from which they
came and, if they carry infection with
them, they can add to increasing rates
of TB in these communities.

Treatment
Periods of incarceration afford opportunities to implement preventive
therapy and tre atment that can help
inmates with TB and protect people
in present and future close contact
with them.
The probability that an infection will
progress to active disease is considerably reduced with preventive therapy.
Individuals who are infected with
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TB are often prescribed a course of
preventive therapy, which involves
taking an anti-tuberculosis medication for 6 to 12 months, depending
on HIV status. The drug most frequently used for preventive therapy
is isoniazid, which can be given daily
or twice weekly. CDC recommends
that a medical worker (or a specially
trained corrections officer) should
watch the inmate swallow each dose

•••

of medication and should monitor the
patient for adverse reactions; this
process constitutes directly observed
preventive therapy. 4
Treatment for TB disease may involve
a battery of drugs. The actions of the
three major anti-TB drugs are different, but each acts in combination with
the body's defenses to effect healing.
Treatment reg~mens are relatively
long.

Tuberculosis Glossary
xtrapulmonary TB: Active TB
where the disease is not localized in the
lungs, but in other anatomical sites such
as the kidneys, spine, or intestines. It is
rarely infectious. Transmission is possible
in the rare cases of contact with a discharge (such as from an open wound)
that contains TB bacilli.
Mantoux (also known as t he PPD)
test: The preferred skin test for detecting

TB infection. A purified protein derivative
(ppd) of killed TB bacteria is injected between the top layers of the skin. Between
48 and 72 hours later, a health care
worker determines the presence or absence of TB infection based on the diameter of the swelling at the injection site.
Multi-drug Resistant TB (MDR-TB):

Primary or Reactivat ion TB that is resistant
to at least two TB medications, most
commonly isoniazid and rifampin. MDRTB occurs primarily in individuals with
active disease who interrupted, inaccurately followed, or failed to complete
the initially prescribed medical reg imen,
Mycobacterium bacilli: The Latin medi-

cal term for the Tuberculosis bacteria.
Primary TB : The infection progresses
directly to active disease within a few
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months to a year or 2 after initial infection. This occurs in about 5 percent of
newly infected persons, but may be more
common in individuals with HIV infection
or other immunosuppressive conditions.
Pulmonary TB: Active TB where the disease is localized in the lungs. This form of
the disease is usually infectious since the
bacilli move easily into the air through tiny
droplets exhaled when individuals with
pulmonary TB cough or sneeze.

Pulmonary TB should be suspected among
offenders with heavy coughing, chest
pain, hoarseness, and spitting blood,
which are indicative of advanced stages
of the disease. Offenders with these
symptoms should receive a chest radiograph and bacteriologic examination of
sputum in order to confirm the diagnosis
of TB regardless of the skin test result.
Reactivation TB: TB infection is latent

for 1 or 2 years, sometimes longer, but
then progresses to active disease. Overall,
infected persons have an estimated 5 to
10 percent risk of developing active disease during their lifetime. For persons
co-infected with TB and HIV, the risk
increases dramatically to 10 percent
each year.
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Individuals with active disease must
be isolated until they are no longer
infectious and must generally take two
or more anti-tuberculosis medications
for 6 to 12 months, again depending on
HIV status and drug susceptibility test
results. Again, CDC recommends directly observed therapy in treatment
of active disease. 5
By completing the prescribed course
of treatment, persons with active infectious disease can achieve a noninfectious state where the progress of the
disease is arrested. Incomplete or
inconsistent treatment can result in
the development of drug resistance.
This drug-resistant TB (MDR-TB)
can then spread to other noninfected
individuals. The emergence of drug
resistance has posed serious problems
for TB control. In some cases of MDRTB, effective drug regimens have not
been identified.

Control
Public health measures can help to
interrupt the cycle of disease transmission and safeguard those who work and
live with inmates or former inmates.
While in prison, inmates may be
encouraged to be more compliant
with treatment regimens. Monitoring
mechanisms, such as directly observed
therapy and directly observed preventative therapy, are easier to implement
because of the greater control maintained over inmates than over citizens
in the outside community. Indeed,
CDC found that nearly 30 percent
more correctional inmates than drug
treatment clients completed their TB
therapy. 6
Infection control measures should be
introduced whenever there is a risk of
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disease transmission. Facility infection
control measures include the improvement of ventilation and the use of air
filters and ultra-violet light. Individual
control measures include:
• Isolating persons with known or
suspected active TB.
• Monitoring TB infection status
through the tuberculosis skin test to
permit action to be taken where there
is evidence of new infection.

e Ensuring that those who are
infected or have TB comply with
treatment regimens.

e Limiting close contacts with
persons who have active TB.

• Asking all people to cover their
mouths when coughing and dispose
of soiled tissues in a careful manner.
These activities can continue into the
community corrections system once
the prisoner is released. Even though
the offender is no longer incarcerated,
he or she is still under the jurisdiction
of the criminal justice system, is reporting regularly to a parole officer,
and may be living in housing arranged
by this system.
The correctional system's contacts
with community corrections organizations can be used either to establish or
encourage the releasee's continued involvement with a public-health-based

Tuberculosis in the United States
uberculosis is a mycobacterial disease with a worldwide distribution. In the
United States prior to 1985, the incidence
of TB had been declining steadily for several decades, with an average annual decline of about 5.8 percent. Between 1985
and 1992, however, the number of TB
cases increased by 20 percent.
Who contracted TB in the United
States during this period of resurgence?
Research has shown that:
• Two-thirds of the "excess" cases-that
is, the cases in excess of the numbers that
would have been expected had the pre1985 downward trend continued-were
among males, and 90 percent of these
cases were among individuals 25 to 44
years of age. 7
• Increases in TB were also found to be
heavily concentrated among racial and
ethnic minorities, with case rates per
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100,000 ranging from 4.0 per 100,000
in non-Hispanic whites to 46.6 in Asians
and Pacific Islanders.
• Immigrants accounted for 60 percent
of the total increase in the number of TB
cases in the United States.
• Five States accounted for 92 percent
of the total U.S. increase: California,
Florida, New Jersey, New York, and
Texas. The number of TB cases grew fastest in States with high cumulative rates
of HIV/AIDS, which is not surprising given
the established relationship between HIV
and TB. 8
• There was also a definite trend in
the average annual incidence of TB according to socioeconomic status. Estimates ranged from 4.2 per 100,000 in
the group with the highest median
household income, to 33 per 100,000
in the group with the lowest-9
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'B program. Integrating an awareness
of the releasee's TB status into the
community corrections process can
also help staff protect themselves from
TB infection and disease. Universal
precautions represent the best approach to infection control. Even when
TB is not thought to be present, clients
and staff should be discouraged from
coughing or sneezing without covering
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their mouths. However, staff should
also be notified when releasees they
are working closely with have active
TB, so they can take additional precautions such as undergoing more frequent TB skin tests. Moreover, efforts
to ensure that releasees have access to
treatment and are compliant with
medication regimens will be beneficial
both for them and the community.

I

Current practices in six
jurisdictions
Several jurisdictions have implemented procedures designed to introduce collaboration between public
health and community corrections
agencies, in an effort to help control
the spread of TB. Their experiences
are discussed below and summarized
in exhibit l.

Exhibit 1. TB Control Strategies in Six States

States
New York

Testing
Screemng for
both parolees
and staff.
Frequency
depends on
TB status.

Arkansas
For inmates and
at hiring for employees.

Discharge/Compliance

Education

Parole officers receive medical data
on parolees.
Parolees receive referrals to medical
providers.

Interagency Cooperation
Intensive Releasee Assistance Program for clients
with HIV and TB.

Given to parolees,
their heads of household, and staff.

Incentives for compliance with
treatment.

Matching program with health department to
identify parolees noncompliant with TB regimen .
Housind program for parolees co-infected with
HIV an TB.

Medication and counseling on release
provided by county health departments.
Failure to seek treatment is a parole
violation.

TB education for
PPD-positive inmates.

Cooperation between criminal justice and
health authorities.

Georgia
5taff are tested.

Policy under development.

Currently no educalion on TB; only on
HIV/AIDS ,

Interagency task force is defining policy on HIV,
TB, and Hepatitis B.

Mandatory
screening for
parolees in
residential
placements.

Failure to comply with treatment is a
parole violation.

Staff training and distribution of materials.

Networking among agencies, including the
Departments of Corrections and Probation
and Pa role.

Inmates with infectious TB are placed
in isolation in hospitals instead of
being released to community.

Correctional officers
and inmates receive
trai ning on bloodborne pa th~ens and
TB. No TB e ucation
for parolees.

Criminal justice and health agencies collaborated
en 1993 TB screeni ng statu te and are work ing
together on policy for providing TB medications.

TB training program
for mana!ilerial staff
of institutional and
community corrections agencies.

Close cooperation between criminal justice and
health authorities in drafting and implementing
TB laws,

South Carolina

Minnesota
Mandatory
annual screening
of ·co rrectional
inrnales.

County health departments are
responsible for ensuring compliance.

Texas
M<.mdatory testir1g of correctional inmates
and staff, but
not parolees.

Employees with positive tests must
show physicans' proof that they do
not have active TB.

~ii?
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New York State
The incidence of TB disease is much
higher in New York (and in the other
heavily urban States of the Northeast
and Middle Atlantic regions) than in
other parts of the country. Control
measures appropriate and necessary
in New York may not be as necessary
outside large urban areas.
The New York State Division of Parole
has developed a series of TB policies.
Approximately 180 persons with active
(and potentially infectious) TB are released from State correctional facilities
into the New York City community
each year. 10
TB screening policies. New York has
separate guidelines for inmates who
are infected with TB, those who have
active disease but are not infectious,
and those who have active disease
and are infectious. TB screening is
required for both parolees and staff.
TB status is determined on admission
to a program (including drug and alcohol treatment programs), and followup
testing is conducted for clients who
have had negative tests. All staff receive preemployment screening for
TB, but those at the highest risk of
exposure are tested every 6 months.
Testing is performed by the Employee
Health Service at the worksite and by
local health care organizations. These
policies are intended to protect the
health and welfare of both staff and
parolees.
Because of this staff safety emphasis,
the Division of Parole has considered
it natural and necessary to involve
the officers' union in the development
of TB policy and training. A TB training curriculum was designed by a
joint task force of labor and management. The Division of Parole has
also brought in a regular medical
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consultant for the first time. All of
these initiatives have resulted in good
cooperative working relations between
management and labor on TB issues.
Despite relatively high annual rates
of skin test conversions among parole
staff (5.6 percent per year statewide,
but as high as 23 percent per year in
some New York City sites), staff alarm
regarding TB has been effectively
defused.
Discharge planning policies andr
procedures. Discharge planning for
inmates with TB is a critical starting
point for an effective community corrections TB policy. Through a collaborative effort between leaders and line
staff of the New York State Department of Correctional Services (DOCS),
the State Division of Parole, and the
Health Department, some effective
discharge planning and followup procedures for inmates with infectious
TB have been developed. Unfortunately, because of resource limitations,
the same level of service is not given
to persons on TB preventive therapy.
The facility parole officer includes information on TB status and the treatment regimen on the medical summary
for each releasee with TB infection or
active disease. Compliance history
and plans for medical followup are
checked. Consent forms for releasing
medical information are obtained from
the inmates. If consent is given, the
discharge summary is sent to the
Health Department in the county to
which the individual is being released.
However, even if consent is refused,
State law requires notification of the
Health Department of all cases of
active TB. The medical summary is
sent to the field parole officer. Before
the prisoner is released, he or she is
given instruction on the importance

I
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of complying with TB treatment or
prophylaxis as well as a referral to
a public-health-based TB program.
Releasees also receive a supply of
their medications.
All persons with active TB who are
about to be released are given an
appointment with the Health Department or a private care provider in the
community in which they will live.
The referral and appointment sheet
includes the names and telephone
numbers of three individuals (who actually have knowledge of the case): a
DOCS health services staff member, a
Division of Parole staff member, and
a Health Department staff member or
private health care provider.
Each New York City releasee with
active TB also receives an incentive
to follow through on treatment-a $25
voucher good for transit tokens or food
coupons. One-half of the value is redeemable upon keeping the first treatment appointment and the other half
on completion of 1 week's directly
observed therapy. Outreach workers
employed by the New York City Department of Health assist in locating
patients and inducing them to remain
on their medication.
Compliance in the community. As
a result of these and other strategies,
overall compliance with medication
regimens among persons with active
TB released from New York City correction facilities has increased from
about 10 percent to about 70 percent
in a single year.
Inmates determined to be infectious
are released to health care facilities
for isolation and treatment until they
are no longer infectious. Such parolees
are permitted to make arrival reports
to their parole officers by telephone

Research

·ather than in person. The parole officer then contacts the health care facility to arrange to be informed when
the parolee is no longer infectious.
Once the individual is released to the
community, his or her field parole officer reviews the medical summary
and discusses treatment status with
the parolee. The officer also provides
additional referrals as needed and ensures that the file contains a consent
to release medical information. Even
where no consent is obtained, the field
parole officer is expected to contact
the county or city health department
to provide information that can facilitate followup with the releasee.

If a parolee is discovered after release
to be infectious or to have been infectious while incarcerated, the parole
division is responsible for identifying
and advising staff who may have had
lignificant contact with the individual.
Specific recommendations are made
for different situations.
The Releasee Assistance Program
(RAP) is a specialized program of the
New York Division of Parole for clients with HIV disease and TB. RAP
serves only New York City, where
most of these patients live, and provides intensive case management,
crisis intervention, medical advocacy,
and other supportive services. RAP
parole officers, who have much smaller
than normal caseloads, have provided
critical assistance to many parolees
in the areas of medical care, housing,
entitlements, substance abuse treatment, and reestablishment of relations
with their families. RAP parole
officers do not provide directly observed therapy for parolees on TB
medications. However, the program
·.vorks with parolees to adhere to their
regimens and offers incentives for
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adherence, such as vouchers for
subway tokens and food coupons.
TB education programs. Education
about TB is available for parolees in
New York State, as well as for families
of parolees and for parole staff. The division issues an information kit called
"A Healthy New Start" to all persons
being released on parole. The kit is
also sent to the head of the household
to whom the inmate will be released.
The Division of Parole also has a tuberculosis training program for staff,
including information on symptoms,
infection control measures, treatment,
the connection between HIV and TB,
the problem ofMDR-TB, contact investigation, case reporting, and Division of Parole procedures for contact
between staff and releasees.
Cooperation with health department.
There has been active cooperation
and information sharing on TB cases
between the State Department of
Health and the Division of Parole.
The New York State Department of
Health assisted the Division of Parole
with information and advice on development of policies, guidelines, and
education programs and materials.
In the spring of 1994, the Bureau of
Tuberculosis Control of the New York
City Department of Health and the
State Division of Parole agreed to
conduct a pilot data matching program, in which the Division of Parole
assisted in the location and return to
treatment of parolees with TB who
were non-compliant with medication
regimens. This was done by matching
the list of "unable to locate" cases provided by the Health Department with
the data base of parolees maintained
by the Division of Parole. Health Department personnel, in turn, informed

• ••
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the appropriate parole officer of
control measures or precautions that
should be used in further contacts
with the parolee. This pilot program
identified only 6 complete matches
out of 100 names; 1 of these individuals was subsequently located. The
number of matches achieved in this
pilot test was lower than expected.
Another match of 100 names from
the Health Department's "unable to
locate" list and the parolee data base
was attempted during 1994, and no
matches were found. Health Department staff suspect that this result
may have been an outcome of better
followup with State prison parolees
so that they rarely appeared on the
"unable to locate" list. In any case,
another match attempt will probably
be made during 1995.
Although the New York experience
has not yielded many matches, the
approach remains a promising strategy
for jurisdictions seeking to improve
TB followup with parolees and others
released from correctional facilities.
This matching program illustrates important differences in the perceived
roles of agencies that are attempting
to forge cooperative relationships to
combat TB. Under the program, the
Parole Division helps locate parolees
who are noncompliant with TB treatment, but the Health Department does
not reciprocate by helping the Parole
Division locate persons who are violating their conditions of parole. This is
because the success of the Health Department, as a health agency rather
than a justice system agency, depends
on b_uilding trust with clients; disclosing information to criminal justice or
immigration authorities would quickly
undermine this trust.
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The most recent example of interagency cooperation with respect to TB
in New York is in the development of
a community-placement pilot program
for housing individuals co-infected
with HIV and TB. The Department of
Conectional Services, the Division of
Parole, and the AIDS Institute of the
Health Department are working together to identify two or three sites for
this purpose. The facilities will be
open to the community at large, and
thus other agencies could place patients there as well. The Division of
Parole will be able to place its clients
in these residential facilities but will
not be guaranteed a fixed number of
beds in them.
Arkansas
The TB control program in the Arkansas Department of Corrections (ADC)
is funded through a grant from the
Centers for Disease Control and Prevention. A central TB Control Program
Director oversees both the Health
Department and ADC, and an ADC
employee directs TB control activities
for inmates and those about to be
released.

Prisoners being released who are receiving medication for TB treatment
or prophylaxis leave the facility with
a supply of medication, and a notification letter is sent to the health department in the county where they will
live. Medication and counseling
are provided by the county health
departments free of charge to the parolees. Parolees in Arkansas who are
on TB medication must, as a condition
of their parole, report to their county
health department within 7 days of
their release. If a releasee does nor
show up for treatment, the health department notifies the parole officer,
as failure to seek treatment constitutes
a parole violation in Arkansas.
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The county health departments supervise TB treatment and medication
compliance. Parole officers become
involved if parolees fail to show up
for treatment but are not otherwise
charged with responsibilities for testing, refenal, and the monitoring of
compliance in Arkansas. The county
health departments monitor treatment
compliance for parolees more closely
than for other patients, but directly
observed therapy is not the norm.
Arkansas community corrections staff
are tested for TB infection when they
are hired. In late 1994, State officials
implemented a mandatory TB screening program for conections staff, paid
for by ADC and performed by the
county health departments.
Georgia
An interagency task force involving
representatives from the State criminal
justice system and the State health
department is drafting a policy for infectious disease control in community
conections that will cover HIV, TB,
and Hepatitis B. Agencywide staff
testing for tuberculosis infection
was undertaken in the State's parole
agency in 1992. This was intended to
serve as a baseline. Staff screening
was canied out again in the fall of
1994, and the agency is working toward a policy of annual testing. Testing is done through the conectional
system's health services facilities,
except when a parole officer is too far
from such a facility. In these cases,
testing is done at a nearby county
health department. As yet, however,
there is no screening of parolees in
Georgia.
South Carolina
The Department of Probation and Parole is not routinely notified of the TB
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status of parolees. Rather, the Depart- ·
ment of Conections notifies the appropriate county health department when
parolees with TB are released to that
jurisdiction.
Parolees in residential placements (for
example, restitution centers, half-way
houses) receive mandatory annual
screening for TB infection. Parolees
living at home are not required to undergo annual testing, however. Parole
officers are required to send parolees
with suspected active TB for followup.
Failure to comply with treatment for
active TB may be a parole violation in
South Carolina if the offender has been
notified of his or her obligations in
this regard. During the last year there
has been increased interagency networking in South Carolina intended
to enhance TB control in community
corrections. There have also been increases in inservice staff training and
distribution of informational materials
on TB to community corrections staff.
Minnesota
In Minnesota, a State statute provides
for TB screening of inmates and employees of facilities operated, licensed,
or inspected by the Department of Corrections. However, it does not cover
parole officers, who are not viewed as
being at risk in Minnesota. Neither
officers nor parolees receive annual
screening for TB.

Under no circumstances are inmates
with infectious TB released to live in
the community in Minnesota. Instead,
they are placed in isolation in hospitals. Inmates who need TB preventive
therapy are referred to a county health
department. It is not a responsibility
of the parole officer in Minnesota to
determine whether or not a parolee is
compliant with treatment regimens.
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Texas law requires TB screening of inmates, staff, and volunteers in county
jails, prisons, and other community
corrections settings. Parolees living in
the community are not required to be
screened for TB, however. Employees
and volunteers must be tested for TB
infection, and if they test positive,
must show proof from their own physicians that they do not have active TB.
The employee must pay the expense of
the screening test and any followup or
treatment. Inmates must be tested if
they are to be confined in any facility
for more than 14 days. The Texas Department of Health supplies the materials for testing and treatment, and the
Texas Department of Criminal Justice
provides funds for administering the
screening, further testing, and treatment for offenders suspected of having
active TB disease. Counties share in
his funding for certain classes of inmates. TB cases must be reported to
the appropriate health authority within
3 days.
The Texas Department of Criminal
Justice and the Department of Health
worked closely together to draft the
law relating to TB screening and treatment for staff and inmates of county
jails and other correctional facilities .
The implementation of the law also
necessitated close cooperation.
A TB training program is offered periodically by health departments at the
judicial district level in Texas. So far,
this training has been provided to
management staff of institutional
and community corrections agencies
but not to inmates or parolees.

Implications
~ole definitions. Disease control is
outside the normal scope of perceived

How Health Departments and Community Corrections
Agencies Can Work Together
espite the complexities involved in
working out TB control programs, the
benefits for the community, for community corrections staff, and for clients are
clear. Departments of public health,
charged with protecting the public from
the spread of disease, and faced with addressing this mission in a population that
may be particularly at risk for developing
TB, often have no systematic knowledge
about populations involved with the criminal justice system or awareness of how to
use the information that does exist to ensure uninterrupted compliance with TB
therapy. Progress toward achieving high
rates of treatment completion can be
greatly enhanced through collaboration
with community corrections agencies.
Community corrections staff, charged
with overseeing the reintegration of offenders into the community, can better
protect themselves, their clients, and their
communities by knowing about TB, participating in an active screening program,
being aware of the TB status of their clients, knowing whether their clients are
compliant with treatment, and encouraging their compliance.
Health departments can provide:
• Assistance in developing and evaluating polices and procedures (including
systems for maintaining records) for TB
control.

responsibility and operation for most
community corrections agencies.
Like other criminal justice agencies,
probation and parole departments
see their primary purpose as law enforcement. The addition of a such a
role in coordinating and monitoring
TB treatment and compliance with
medication regimens may also be seen
to increase the workload of already

•

9

•

• Training of correctional facilites staff
responsible for implementing TB control
program.
• Information about TB to educate staff
and the offender population .
• Coordination of services for screening,
treatment. and prophylaxis for clients and
staff of community corrections agencies.
• Investigation of contacts that TB
patient has had within the correctional
system and in the community.
Community corrections, in turn, can help
health departments by:
• Referring clients with TB symptoms to
TB programs.
• Helping to ensure TB treatment
compliance.
• Helping locate noncompliant clients
by offering to cross-match lists of
parolees with health department lists of
noncompliant individuals (as in New York
City's pilot program).
As health departments and correctional
systems establish linkages and begin to
work together, other areas of potential
collaboration may evolve, such as in HIV
or other infectious diseases.

overburdened and understaffed
community corrections agencies.
However, it is in the best interests of
staff who must work closely with offenders to be aware of TB cases and to
be able to work toward protecting their
own health as well as the health of
their clients and of the public. The
most important reason for establishing

•••
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a new TB control role for community
corrections staff may be to ensure their
own and their families' health.
Lack of knowledge. Clarification of
roles is not the only challenge. Lack of
information and knowledge is another
significant barrier to the effective involvement of community corrections
staff in TB control. Parole and probation officers may know very little about
TB or its means of transmission. They
may not have information about resources to which they can refer their
clients for care and treatment. Indeed,
they may not be aware of available
anti-TB medications. Further, community corrections staff may not be
aware of the importance of treatment
compliance, or of any of the other dimensions of TB control on which they
may be able to have some impact in
their day-to-day work with their clients. Education and training programs
are needed to address these gaps in
knowledge.
Particular problems of probation.
There can be little discharge planning
with regard to probationers except for
those who spend pretrial time in jail.
Universal TB screening of probationers and followup diagnostic workups
on suspect cases of TB disease would
provide information as to the medical
needs of clients, but such a policy
would be costly to implement. Given
these obstacles, probation agencies
are likely to receive little if any information on the medical needs of their
clients.
Interagency cooperation. Interagency
communication and information
sharing are extremely important in
effective discharge planning and community followup. However, medical
records and information on TB status
often do not accompany prisoners as
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they leave their institutions. Probationers and parolees living on their
own in the community may see no
reason to divulge information
concerning their TB status. Healthrelated information is generally considered confidential, and working out
a system involving medical release
forms and practices that protect
the privacy of clients may pose an additional difficulty for community corrections agencies. As correctional
programs and health departments begin to work together, the whole area
of confidentiality must be carefully
considered.

violation. Providing refe~;rals for care 1
may constitute another level of involvement for community corrections
staff. Offering incentives for seeking
and complying with treatment may
also be considered for inclusion in a
TB control effort. Such incentives may
include additional services provided in
a caring manner, as well as vouchers
for transportation or food. Approaches
combining incentives and threatened
sanctions may work best. It is a delicate balance, a key to which is winning the confidence of clients that both
the incentives and the sanctions will
be forthcoming as appropriate.

Close inter- and intra-agency collaboration is needed for the integration of
TB control into the accepted mission
of community corrections. This takes
time, effort, and commitment from
all participants. The fact that public
health and criminal justice agencies
may have very different perceptions
of their roles and responsibilities may
pose difficulties as potential collaborations are explored. In the States where
TB control programs in community
corrections already exist, the health
department has usually played a key
role in offering training and developing materials for use in inservice education, as well as providing screening
and treatment services for clients and
staff.

Community corrections agencies
have services to offer health departments in an attempt to achieve better
TB control (see "How Health Departments and Community Corrections
Can Work Together"). To the extent
that they use these servic l'i, 1bey ·an
1
reduce the probability of infec tion
among their own staff and reduce the
spread of disease in the surrounding
community. In the case of repeat
offenders, they can also minimize the
reintroduction of TB into correctional
populations.

The role of community corrections
staff in TB control must be defined.
This can be difficult, as a number of
possibilities exist, each of which may
have its own supporters within an
agency. Community corrections staff
may assist health departments by
trying to locate clients who are noncompliant with treatment. They may
also be given a significant role in enforcing treatment compliance if noncompliance is specified as a parole

•
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The potential impact that these agencies can have is of course shaped by
the dimensions of the TB problem in
their own jurisdictions. Even where
the prevalence ofTB is low, however,
an isolated case of TB in prison can
lead to an outbreak; and if controls
like screening are in place, at least
some level of protection is available.
Where the prevalence of TB is high,
such as in New York City and other
major metropolitan centers, and known
cases of active TB reenter the community each year, the involvement of
community corrections programs is
even more critical in controlling the
spread of the disease.
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